Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): A randomised controlled trial

1. Herbst, R.S.
2. Baas, P.
3. Kim, D.-W.
4. Felip, E.
5. Pérez-Gracia, J.L.
6. Han, J.-Y.
7. Molina, J.
8. Kim, J.-H.
9. Arvis, C.D.
10. Ahn, M.-J.
11. Majem, M.
12. Fidler, M.J.
13. De Castro, G.
14. Garrido, M.
15. Lubiniecki, G.M.
16. Shentu, Y.
17. Im, E.
18. Dolled-Filhart, M.
19. Garon, E.B.